Content Preview: rss
A reporter compares the two healthcare reform bills moving through the House and Senate, explaining how the changes could affect you and your medical care.
The U.S. Food and Drug Administration has approved a new skin patch called Qutenza to treat postherpetic neuralgia, the nerve pain that may follow shingles.
An analysis by the Henry J. Kaiser Family Foundation has found that monthly premiums will rise an average 11 percent, though the premium changes vary widely by which plan seniors select.
Drugmakers say the current FDA guidelines requiring both benefits and risks of drugs on ads hampers advertising on the Internet given the space constraints for ads on Web pages.
According to new research, chronically ill patients who give up hope that they will get better are actually happier than people who have not accepted their condition.
